CAMBRIDGE, Mass., June 18, 2025 /PRNewswire/ — Biobot Analytics, the leader in wastewater intelligence, today announced a new round of funding led by Valor Equity Partners. Alongside Valor, Biobot is also welcoming new investor Atreides Management, as well as participation from existing investors, including Hyperplane. The investment reflects strong ongoing support for Biobot’s mission to build a wastewater intelligence platform for healthcare and national security applications.
The capital will support the company’s expanding suite of wastewater intelligence offerings, enabling continued innovation in advanced analytics, product development, and partnerships across government and commercial sectors.
As part of this round, Biobot is pleased to welcome new board members:
They join Biobot’s cofounders and existing Board Directors, Dr. Mariana Matus and Newsha Ghaeli, in guiding the company’s long-term strategy.
“We are proud to be backed by some of the most forward-thinking investors in the tech industry,” said Dr. Mariana Matus, CEO of Biobot Analytics. “Their support and insight will be instrumental as we build a new category of health intelligence—using wastewater data to create a safer, healthier, and more resilient society.”
“Biobot is a category-defining company with a bold vision for the future of healthcare and biosecurity,” said Vivek Pattipati, Partner at Valor Equity Partners. “We’re excited to support the talented team at Biobot as they bring innovative new products to market.”
Founded at the Massachusetts Institute of Technology, Biobot Analytics pioneered wastewater-based epidemiology in cities. From tracking COVID-19 trends across hundreds of communities to detecting opioid use and other health indicators, Biobot’s technology empowers governments and organizations with critical data.
About Biobot Analytics
Biobot Analytics is the global leader in wastewater intelligence. By analyzing wastewater, Biobot delivers real-time, community-wide insights into population health, empowering governments and organizations to identify outbreaks, monitor behavioral trends, and prepare for emerging threats. Learn more at www.biobot.io.
SOURCE Biobot Analytics, Inc.
After President Trump's Marijuana Executive Order, Will the DEA Act-or Be Compelled by the Courts?"Despite…
Boards and executive buyers are raising the 2026 bar for all product and service rankings…
Boards and executive buyers are raising the 2026 bar for all product and service rankings…
Tampa based Celebrity Board-Certified Plastic Surgeon Dr. Meegan Gruber expands an interactive approach that allows…
Clemson University and Nordic Wellness have launched a pioneering partnership tackling the student mental health…
Telehealth Platform Offers Compounded GLP-1 Injections and Oral Tablets at $299/Month With No Contract as…